Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.

NCT NCT02265913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02265913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
Lead sponsor
Padagis LLC
Phase
Phase 3
Overall status
Completed
Start date
October 6, 2014
Completion date
November 21, 2017
Enrollment
4,076 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis